Creating opportunities for black markets and civil disobedience
Producing and selling weed (of a synthetic variety) to the world, while keeping it strictly illegal at home.
A few days ago the U.S. Food and Drug Administration unanimously recommended approval of an epilepsy medication made with cannabidiol (or CBD), an ingredient found in marijuana. If the agency follows the recommendation, as is expected, the drug would be the first cannabis-derived prescription medicine available in the United States.
The drug, called Epidiolex, is manufactured by GW Pharmaceuticals, a British company that is licensed by the UK Home Office to conduct research into the medicinal uses of cannabis. Its active ingredient, cannabidiol, also called CBD, is one of the chemical compounds found in the cannabis plant, but it does not contain the properties that get people high.
GW boasts of being the “global leader” in developing synthetic cannabinoid-based medicines. In 1998 the company bought exclusive rights to the entire range of cannabis varieties…
View original post 828 more words